Prostate Cancer Clinical Trials in Tampa, FL

Prostate Cancer Clinical Trials in Tampa, FL

View the best 10 prostate cancer medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Prostate Cancer clinical trial.

Trials in Tampa, Florida

Here are the top 10 medical studies for prostate cancer in Tampa, Florida

Image of VA Greater Los Angeles Healthcare System, West Los Angeles, CA in West Los Angeles, United States.

Carboplatin +1 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is comparing the efficacy of two treatments for patients with metastatic castrate resistant prostate cancer who have tumors containing BRCA1, BRCA2 or PALB2 inactivating DNA mutations.
Image of UCLA Jonsson Comprehensive Cancer Center in Los Angeles, United States.

ARV-110

Androgen Receptor Degrader

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called ARV-110 to see if it is safe and can be tolerated by men with advanced prostate cancer that has not responded to other treatments. The drug aims to break down proteins that help cancer cells grow.
Image of VA Greater Los Angeles Healthcare System in Los Angeles, United States.

[Lu-177]-PNT2002

Radioisotope Therapy

Recruiting2 awardsPhase 3
This trial is testing a radioactive treatment in patients with advanced prostate cancer that hasn't responded to other treatments. The treatment targets and kills cancer cells using radiation and has shown promising outcomes, including reduced disease progression and improved overall survival.
Image of Arizona Urology Specialists, PLLC in Tucson, United States.

Relugolix +1 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial compared the safety and heart-related risks of two hormone-lowering medications, relugolix and leuprolide acetate, in adults with prostate cancer. These drugs help manage cancer by reducing testosterone levels. The study was discontinued, but patients can continue their treatment for a certain period. Relugolix is the first oral medication of its kind and was approved by the FDA based on previous study results.
Image of GenesisCare USA in Troy, United States.

Stereotactic Body Radiotherapy

Radiation Therapy

Recruiting1 award
This trial shows that the SpaceOAR system is effective in reducing late GI toxicity in people undergoing SBRT to treat prostate cancer.
Image of NCT02257736 in Phoenix, United States.

Prednisone +2 More

Corticosteroid

Recruiting1 awardPhase 3
This trial tests apalutamide added to a standard treatment for advanced prostate cancer. It targets patients whose cancer has spread and who haven't had chemotherapy. The treatment works by blocking and lowering male hormones that help cancer grow. Apalutamide has shown efficacy in treating different stages of prostate cancer.
Image of Clinical Trial Site in La Jolla, United States.

ARV-766

Androgen Receptor Antagonist

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug called ARV-766, alone or with abiraterone, in men with advanced prostate cancer that has spread. The drug works by blocking proteins that help cancer cells grow. Abiraterone is a well-established drug used in the treatment of metastatic castration-resistant prostate cancer, often in combination with other therapies.
Image of Urology Centers Of Alabama in Homewood, United States.

Niraparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial will compare the effect of adding niraparib to abiraterone acetate plus prednisone, versus abiraterone acetate plus prednisone and placebo, in men with metastatic castration-resistant prostate cancer.
Image of VA Greater Los Angeles Healthcare System, West Los Angeles, CA in West Los Angeles, United States.

Pembrolizumab

Checkpoint Inhibitor

Recruiting2 awardsPhase 2
This trial is testing the efficacy of pembrolizumab, a checkpoint inhibitor, in Veterans with metastatic castration-resistant prostate cancer. The study will also compare the pre-treatment and at-progression metastatic tumor biopsies to investigate the molecular correlates of resistance and sensitivity to pembrolizumab.
Image of University of Alabama at Birmingham in Birmingham, United States.

Enzalutamide +1 More

Antiandrogen

Recruiting1 awardPhase 3
This trial will test whether adding the drug enzalutamide to leuprolide helps patients with high-risk prostate cancer that has come back after surgery or radiotherapy.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.